Á¦38Â÷ ´ëÇѼöÇ÷ÇÐȸ Çмú´ëȸ : 2019-05-31±³À°ÀÏÀÚ : 2019-05-31
±³À°Àå¼Ò : È£ÅÚÀÎÅͺҰí ÄÁº¥¼ÇȦ ¿Ü 2°³·ë
±³À°ÁÖÁ¦ :
Á¦38Â÷ ´ëÇѼöÇ÷ÇÐȸ Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇѼöÇ÷ÇÐȸ
´ã´çÀÚ : ´ëÇѼöÇ÷ÇÐȸ
¿¬¶ôó : 02-795-7911
À̸ÞÀÏ :
ksbt@kams.or.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 450¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í ÀÇ»ç: »çÀü 70,000¿ø / ÇöÀå 80,000¿øÀü°øÀÇ: »çÀü 50,000¿ø / ÇöÀå 60,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-31 Hall A 09:30~10:00 µ¿Á¾ÀûÇ÷±¸ ÈíÂø¿¡ ÀÇÇÑ º¹ÇÕÇ×üÀÇ ºÐ¸® ¹éÀºÁ¤(ÇѾçÀÇ´ë)
±³À°½Ã°£ 05-31 Hall A 10:00~10:30 ¼öÇ÷ÀÇÇп¡¼ DTT ó¸®ÀÇ È°¿ë ÀÓÁø¼÷(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 05-31 Hall A 10:30~11:00 ¸é¿ª°ü¹®¾ïÁ¦Á¦°¡ ¼öÇ÷ÀÇÇÐ °Ë»ç¿¡ ¹ÌÄ¡´Â ¿µÇâ È«À±Áö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-31 Hall A 11:00~11:30 MNS Ç÷¾×Çü À¯ÀüÇü°Ë»ç ±¸ÇöÁ¤(°æÈñÀÇ´ë)
±³À°½Ã°£ 05-31 Hall A 12:40~13:10 018³âµµ Ç÷¾×»ç¾÷ ÇöȲ ¹× Àü¸Á ¹ÎÇõ±â(´ëÇÑÀû½ÊÀÚ»ç)
±³À°½Ã°£ 05-31 Hall A 13:10~13:50 Occult hepatitis B & C: implications for blood safety Wai-Kay Seto(The University of Hong Kong, Hong Kong)
±³À°½Ã°£ 05-31 Hall A 13:50~14:30 Application of genome editing in transfusion medicine Ashley M Toye(University of Bristol, UK)
±³À°½Ã°£ 05-31 Hall A 15:10~15:40 CAR-T ¼¼Æ÷ Ä¡·á: ÃÖ½ÅÁö°ß °í¿µÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-31 Hall A 15:40~16:10 °£ Àç»ý°ú ¾Ï Àç¹ß¿¡ ÀÖ¾î Ç÷¼ÒÆÇÀÇ ¿ªÇÒ ÇÑ»óºó(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-31 Hall A 16:10~16:40 Çѱ¹¿¡¼ PBMÀÇ µµÀÔ: ¾î¶»°Ô ÇÒ °ÍÀΰ¡? ±è¿µ¿ì(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 05-31 Hall A 16:40~17:10 Ç×Ç÷¼ÒÆÇÁ¦Á¦ Ä¡·á ȯÀÚÀÇ ÁÖ¼ú±â °ü¸® Á¤ÈÆ(°æºÏÀÇ´ë)
±³À°½Ã°£ 05-31 Hall B 15:10~15:40 Clinical significance of HPA antibodies Ai Leen Ang(Blood Services Group of Health Sciences Authority, Singapore)
±³À°½Ã°£ 05-31 Hall B 15:40~16:10 How to screen for anti-platelet antibodies Hirokazu Tsuno(Japanese Red Cross, Japan)
±³À°½Ã°£ 05-31 Hall B 16:10~16:40 Platelet storage lesion¿¡ ´ëÇØ ¿ì¸®°¡ ¾Ë°í ÀÖ´Â °ÍÀº? Á¶¿ë°ï(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 05-31 Hall B 16:40~17:10 Experience of using washed platelets for patients with a history of transfusion reactions Shin-ichiro Fujiwara(Jichi Medical University, Japan)